DeepX Diagnostics

DeepX Diagnostics

Oslo, Norway· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $2.8M

Overview

DeepX Diagnostics is an Oslo-based private company operating at the intersection of diagnostics and artificial intelligence. It focuses on creating software-as-a-medical-device (SaMD) solutions that enhance the analysis of medical images, aiming to reduce diagnostic errors and improve workflow efficiency for radiologists and clinicians. As a pre-revenue or early-revenue stage company, it is likely funded by venture capital and grants while it validates its technology and seeks regulatory approvals. Its success hinges on clinical validation, regulatory strategy, and integration into established healthcare systems.

DiagnosticsAI / Machine Learning

Technology Platform

Deep learning and machine learning platform for analyzing medical images (e.g., X-rays, CT, MRI) to assist in disease detection and diagnosis.

Funding History

1
Total raised:$2.8M
Seed$2.8M

Opportunities

The global AI in medical imaging market is large and growing, driven by imaging volume increases and radiologist shortages.
Integration into public European healthcare systems offers a pathway for pilot projects and early adoption.
The company's technology addresses a clear need for improved diagnostic accuracy and workflow efficiency.

Risk Factors

Key risks include the challenge of obtaining regulatory approvals (CE/FDA), the need for robust clinical validation to prove utility, and intense competition in the AI diagnostics space.
Commercial success also depends on overcoming hospital procurement hurdles and securing reimbursement.

Competitive Landscape

The AI-powered medical imaging diagnostics sector is highly competitive, featuring numerous startups (e.g., Aidoc, Zebra Medical) and established med-tech giants (e.g., GE HealthCare, Siemens Healthineers) developing similar tools. Differentiation requires superior algorithm performance, seamless clinical workflow integration, and clear evidence of improved patient outcomes or cost savings.